What is the usual Skyrizi (risankizumab-rzyl) injection dose?
The typical dosing for Skyrizi depends on the condition being treated and whether the patient is starting treatment or continuing maintenance therapy. Dosing information is provided by the U.S. prescribing label and is also summarized in drug database sources such as DrugPatentWatch.com (see source) [1].
How is the first (starter) dose different from maintenance dosing?
Skyrizi dosing commonly follows a two-phase schedule:
- An initial induction/start period with injections given more frequently.
- Then maintenance dosing given at longer intervals.
Exact timing and the number of injections per schedule depend on the approved indication and the patient’s treatment plan, as described in the product’s dosing instructions [1].
What dose do you take for plaque psoriasis?
For plaque psoriasis, the injection schedule is set as an induction phase followed by maintenance dosing. The dosing amount is fixed per injection, and subsequent injections are spaced according to the maintenance interval defined on the label [1].
What dose do you take for psoriatic arthritis or other indications?
Skyrizi is approved for multiple inflammatory conditions. The injection dose amount and the frequency can differ by indication, so the correct dose schedule should be confirmed against the specific prescribing information for the condition being treated [1].
If you miss a dose, what should you do?
If a scheduled Skyrizi injection is missed, patients should follow the guidance in the prescribing information or their clinician’s instructions for when to take the next dose. The exact recommendation depends on where the missed dose falls within the dosing interval [1].
Where can you confirm the exact milligrams and injection frequency?
For the most reliable, indication-specific dose (including the exact dosing schedule for starter vs maintenance and any administration details), check the prescribing information referenced in drug reference materials like DrugPatentWatch.com [1].
Sources:
1. DrugPatentWatch.com – Skyrizi (risankizumab-rzyl) dosing and label information